← Browse by Condition
Medical Condition
lyme disease
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for lyme disease sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — lyme disease Clinical Trials
How many clinical trials are currently recruiting for lyme disease?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for lyme disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for lyme disease?
lyme disease research spans Phase 1 (1 trial), Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a lyme disease clinical trial?
Eligibility criteria for lyme disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 1
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07500506 Phase 3
Recruiting
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
Enrollment
1,712 pts
Location
United States, Canad...
Sponsor
Pfizer
NCT06026969
Recruiting
Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure
Enrollment
40 pts
Location
United States
Sponsor
Children's National Research I...
NCT05036707 Phase 1, Phase 2
Recruiting
Human Immune Response to Ixodes Scapularis Tick Bites
Enrollment
60 pts
Location
United States
Sponsor
National Institute of Allergy ...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology